| Product Code: ETC10939551 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Estonia continues to rely on neighboring countries such as Lithuania, Finland, and Poland for vaccine imports, with a notable increase in shipments from Germany and Sweden. The high Herfindahl-Hirschman Index (HHI) suggests a concentrated market, while the impressive compound annual growth rate (CAGR) of 16.41% from 2020 to 2024 indicates a thriving vaccine import market. The growth rate of 8.53% in 2024 further emphasizes Estonia`s increasing demand for imported vaccines to support public health initiatives.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Vaccine Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Estonia Vaccine Market - Industry Life Cycle |
3.4 Estonia Vaccine Market - Porter's Five Forces |
3.5 Estonia Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Estonia Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Estonia Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Estonia Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Estonia Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Estonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Estonia Vaccine Market Trends |
6 Estonia Vaccine Market, By Types |
6.1 Estonia Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Estonia Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Estonia Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Estonia Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Estonia Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Estonia Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Estonia Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Estonia Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Estonia Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Estonia Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Estonia Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Estonia Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Estonia Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Estonia Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Estonia Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Estonia Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Estonia Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Estonia Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Estonia Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Estonia Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Estonia Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Estonia Vaccine Market Import-Export Trade Statistics |
7.1 Estonia Vaccine Market Export to Major Countries |
7.2 Estonia Vaccine Market Imports from Major Countries |
8 Estonia Vaccine Market Key Performance Indicators |
9 Estonia Vaccine Market - Opportunity Assessment |
9.1 Estonia Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Estonia Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Estonia Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Estonia Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Estonia Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Estonia Vaccine Market - Competitive Landscape |
10.1 Estonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Estonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here